Literature DB >> 2353348

T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors.

S Yamada1, R Kubota, K Yamada, S Ono, T Hishinuma, T Matsuzawa, S Fujiwara.   

Abstract

MRI of brain tumors was performed with CPMG pulse sequence, and T1 and T2 relaxation times were measured before and after the administration of 0.1 mmol/kg Gd-DTPA. T1 and T2 became significantly shorter than before with the T1 shortening being about twice the T2's. Three types of T2 shortening were classified by the difference in the intra-tumoral transport of Gd-DTPA in the time-course study after the administration. Transportal activity of Gd-DTPA seemed to be reflected by the physiologic viability of tumor suggested by pre-contrast T2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353348     DOI: 10.1620/tjem.160.145

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  An experimental phantom study of the effect of gadolinium-based MR contrast agents on PET attenuation coefficients and PET quantification in PET-MR imaging: application to cardiac studies.

Authors:  Jim O' Doherty; Paul Schleyer
Journal:  EJNMMI Phys       Date:  2017-01-13

2.  Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.

Authors:  Seongjin Choi; Margaret Spini; Jun Hua; Daniel M Harrison
Journal:  PLoS One       Date:  2021-04-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.